Title |
The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca
|
---|---|
Published in |
Clinical Ophthalmology, October 2008
|
DOI | 10.2147/opth.s3023 |
Pubmed ID | |
Authors |
Koray Gumus, Dwight H Cavanagh |
Abstract |
To review and integrate recent advances in identifying the role of inflammation in the pathogenesis of dry eye conditions and the biological rationale and practical clinical aspects of newer, antiinflammatory theories. A comprehensive literature survey. Keratoconjunctivitis Sicca (KCS) is a multifactorial and complex disorder in which ocular surface inflammations play a central role. Identification of specific CD4-T-Cell pathways and the recent recognition of targeting of alpha-fodrin suggest a case for novel new therapeutic aspects such as anti-CD4 monoclonal antibodies, systemic linoleic and gamma-linolenic acids, and omega-6 essential fatty acids. Replacement of tear volume with nonpreserved wetting agents and standard typical antiinflammatory corticosteroid and/or cyclosporine A continues to be central current conventional therapy for KCS. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 45 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 13% |
Student > Master | 6 | 13% |
Student > Bachelor | 5 | 11% |
Professor > Associate Professor | 5 | 11% |
Student > Doctoral Student | 4 | 9% |
Other | 14 | 31% |
Unknown | 5 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 47% |
Agricultural and Biological Sciences | 9 | 20% |
Veterinary Science and Veterinary Medicine | 2 | 4% |
Nursing and Health Professions | 2 | 4% |
Chemistry | 2 | 4% |
Other | 3 | 7% |
Unknown | 6 | 13% |